Alveolar Macrophages: Achilles' Heel of SARS-CoV-2 Infection

Overview

Journal Signal Transduct Target Ther

Specialties Cell Biology
Pharmacology

Date 2022 Jul 19

PMID 35853858

Authors

Zhenfeng Wang

Shunshun Li

Bo Huang

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has caused more than 6.3 million deaths to date. Despite great efforts to curb the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines and neutralizing antibodies are in the gloom due to persistent viral mutations and antiviral compounds face challenges of specificity and safety. In addition, vaccines are unable to treat already-infected individuals, and antiviral drugs cannot be used prophylactically. Therefore, exploration of unconventional strategies to curb the current pandemic is highly urgent. Alveolar macrophages (AMs) residing on the surface of alveoli are the first immune cells that dispose of alveoli-invading viruses. Our findings demonstrate that M1 AMs have an acidic endosomal pH, thus favoring SARS-CoV-2 to leave endosomes and release into the cytosol where the virus initiates replication; in contrast, M2 AMs have an increased endosomal pH, which dampens the viral escape and facilitates delivery of the virus for lysosomal degradation. In this review, we propose that AMs are the Achilles' heel of SARS-CoV-2 infection and that modulation of the endosomal pH of AMs has the potential to eliminate invaded SARS-CoV-2; the same strategy might also be suitable for other lethal respiratory viruses.

Citing Articles

Ultradiluted Prevents and Alleviates SARS-CoV-2 Spike Protein-Induced Lung Pathogenesis by Regulating Inflammatory Response and Apoptosis.

Roy A, Sarkar A, Roy A, Ghorai T, Nayak D, Kaushik S Diseases. 2025; 13(2).

PMID: 39997043 PMC: 11854276. DOI: 10.3390/diseases13020036.

Impaired inflammatory resolution with severe SARS-CoV-2 infection in leptin knock out obese hamster.

Jiang R, Luo Y, Lin H, Zheng X, Zeng W, Liu M iScience. 2025; 28(2):111837.

PMID: 39981511 PMC: 11841202. DOI: 10.1016/j.isci.2025.111837.

Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability.

Mai K, Pan W, Lin Z, Wang Y, Yang Z Adv Biotechnol (Singap). 2025; 3(1):5.

PMID: 39883362 DOI: 10.1007/s44307-025-00057-9.

Lysosomal "TRAP": a neotype modality for clearance of viruses and variants.

Lyu C, He Z, Hu X, Wang S, Qin M, Zhu L Nat Commun. 2024; 15(1):10155.

PMID: 39578473 PMC: 11584657. DOI: 10.1038/s41467-024-54505-6.

Macrophage‑driven pathogenesis in acute lung injury/acute respiratory disease syndrome: Harnessing natural products for therapeutic interventions (Review).

Li J, Ma W, Tang Z, Li Y, Zheng R, Xie Y Mol Med Rep. 2024; 31(1).

PMID: 39513609 PMC: 11551695. DOI: 10.3892/mmr.2024.13381.

References

Weaver T, Na C, Stahlman M . Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol. 2002; 13(4):263-70. DOI: 10.1016/s1084952102000551. View

Du L, Lin L, Li Q, Liu K, Huang Y, Wang X . IGF-2 Preprograms Maturing Macrophages to Acquire Oxidative Phosphorylation-Dependent Anti-inflammatory Properties. Cell Metab. 2019; 29(6):1363-1375.e8. DOI: 10.1016/j.cmet.2019.01.006. View

Tan S, Krasnow M . Developmental origin of lung macrophage diversity. Development. 2016; 143(8):1318-27. PMC: 4852511. DOI: 10.1242/dev.129122. View

Lempp F, Soriaga L, Montiel-Ruiz M, Benigni F, Noack J, Park Y . Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021; 598(7880):342-347. DOI: 10.1038/s41586-021-03925-1. View

Andreakos E, Papadaki M, Serhan C . Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19. Allergy. 2020; 76(3):626-628. PMC: 7537007. DOI: 10.1111/all.14595. View

Scialo F, Daniele A, Amato F, Pastore L, Matera M, Cazzola M . ACE2: The Major Cell Entry Receptor for SARS-CoV-2. Lung. 2020; 198(6):867-877. PMC: 7653219. DOI: 10.1007/s00408-020-00408-4. View

Weiss S, Navas-Martin S . Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev. 2005; 69(4):635-64. PMC: 1306801. DOI: 10.1128/MMBR.69.4.635-664.2005. View

Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

Zamboni N, Maaheimo H, Szyperski T, Hohmann H, Sauer U . The phosphoenolpyruvate carboxykinase also catalyzes C3 carboxylation at the interface of glycolysis and the TCA cycle of Bacillus subtilis. Metab Eng. 2004; 6(4):277-84. DOI: 10.1016/j.ymben.2004.03.001. View

10.

Hashimoto D, Chow A, Noizat C, Teo P, Beasley M, Leboeuf M . Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity. 2013; 38(4):792-804. PMC: 3853406. DOI: 10.1016/j.immuni.2013.04.004. View

11.

Cocozza F, Nevo N, Piovesana E, Lahaye X, Buchrieser J, Schwartz O . Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus. J Extracell Vesicles. 2021; 10(2):e12050. PMC: 7769856. DOI: 10.1002/jev2.12050. View

12.

Cantuti-Castelvetri L, Ojha R, Pedro L, Djannatian M, Franz J, Kuivanen S . Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020; 370(6518):856-860. PMC: 7857391. DOI: 10.1126/science.abd2985. View

13.

Pisu D, Huang L, Narang V, Theriault M, Le-Bury G, Lee B . Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021; 218(9). PMC: 8302446. DOI: 10.1084/jem.20210615. View

14.

Griese M . Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J. 1999; 13(6):1455-76. DOI: 10.1183/09031936.99.13614779. View

15.

cabanova K, Motyka O, cabalova L, Hrabovska K, Bielnikova H, Kuznikova L . Metal particles in mucus and hypertrophic tissue of the inferior nasal turbinates from the human upper respiratory tract. Environ Sci Pollut Res Int. 2020; 27(22):28146-28154. DOI: 10.1007/s11356-020-09156-7. View

16.

Wculek S, Dunphy G, Heras-Murillo I, Mastrangelo A, Sancho D . Metabolism of tissue macrophages in homeostasis and pathology. Cell Mol Immunol. 2021; 19(3):384-408. PMC: 8891297. DOI: 10.1038/s41423-021-00791-9. View

17.

Yunna C, Mengru H, Lei W, Weidong C . Macrophage M1/M2 polarization. Eur J Pharmacol. 2020; 877:173090. DOI: 10.1016/j.ejphar.2020.173090. View

18.

Rao L, Xia S, Xu W, Tian R, Yu G, Gu C . Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines. Proc Natl Acad Sci U S A. 2020; 117(44):27141-27147. PMC: 7959535. DOI: 10.1073/pnas.2014352117. View

19.

Jangra S, Ye C, Rathnasinghe R, Stadlbauer D, Krammer F, Simon V . SARS-CoV-2 spike E484K mutation reduces antibody neutralisation. Lancet Microbe. 2021; 2(7):e283-e284. PMC: 8026167. DOI: 10.1016/S2666-5247(21)00068-9. View

20.

Wittekindt O, Dietl P . Aquaporins in the lung. Pflugers Arch. 2018; 471(4):519-532. PMC: 6435619. DOI: 10.1007/s00424-018-2232-y. View